Arizona Administrative Code (Last Updated: November 17, 2016) |
Title 12. NATURAL RESOURCES |
Chapter 1. RADIATION REGULATORY AGENCY |
Article 7. MEDICAL USES OF RADIOACTIVE MATERIAL |
Section R12-1-701. License Required |
Section R12-1-702. Definitions |
Section R12-1-703. License for Medical Use of Radioactive Material |
Section R12-1-704. Provisions for the Protection of Human Research Subjects |
Section R12-1-705. Authority and Responsibilities for the Radiation Protection Program |
Section R12-1-706. Supervision |
Section R12-1-707. Written Directives |
Section R12-1-708. Procedures for Administrations Requiring a Written Directive |
Section R12-1-709. Sealed Sources or Devices for Medical Use |
Section R12-1-710. Radiation Safety Officer Training |
Section R12-1-711. Authorized Medical Physicist Training |
Section R12-1-712. Authorized Nuclear Pharmacist Training |
Section R12-1-713. Determination of Prescribed Dosages, and Pos- session, Use, and Calibration of Instruments |
Section R12-1-714. Authorization for Calibration, Transmission, and Reference Sources |
Section R12-1-715. Requirements for Possession of Sealed Sources and Brachytherapy Sources |
Section R12-1-716. Surveys of Ambient Radiation Exposure Rate, Surveys for Contamination, and PET Radiation Exposure Con- cerns |
Section R12-1-717. Release of Individuals Containing Radioactive Material or Implants Containing Radioactive Material |
Section R12-1-718. Mobile Medical Service |
Section R12-1-719. Training for Uptake, Dilution, and Excretion Studies |
Section R12-1-720. Permissible Molybdenum-99, Strontium-82, and Strontium-85 Concentrations |
Section R12-1-721. Training for Imaging and Localization Studies Not Requiring a Written Directive |
Section R12-1-722. Safety Instruction and Precautions for Use of Unsealed Radioactive Material Requiring a Written Directive |
Section R12-1-723. Training for Use of Unsealed Radioactive Mate- rial Requiring a Written Directive, Including Treatment of Hyperthyroidism, and Treatment of Thyroid Carcinoma |
Section R12-1-724. Surveys after Brachytherapy Source Implant and Removal; Accountability |
Section R12-1-725. Safety Instructions and Precautions for Brachytherapy Patients that Cannot be Released Under R12-1- 717 |
Section R12-1-726. Calibration Measurements of Brachytherapy Sources, Decay of Sources Used for Ophthalmic Treatments, and Computerized Treatment Planning Systems |
Section R12-1-727. Training for Use of Manual Brachytherapy Sources and Training for the Use of Strontium-90 Sources for Treatment of Ophthalmic Disease |
Section R12-1-728. Training for Use of Sealed Sources for Diagnosis |
Section R12-1-729. Surveys of Patients and Human Research Sub- jects Treated with a Remote Afterloader Unit |
Section R12-1-730. Installation, Maintenance, Adjustment, and Repair of an Afterloader Unit, Teletherapy Unit, or Gamma Stereotactic Radiosurgery Unit |
Section R12-1-731. Safety Procedures and Instructions for Remote Afterloader Units, Teletherapy Units, and Gamma Stereotactic Radiosurgery Units |
Section R12-1-732. Safety Precautions for Remote Afterloader Units, Teletherapy Units, and Gamma Stereotactic Radiosurgery Units |
Section R12-1-733. Dosimetry Equipment |
Section R12-1-734. Full Calibration Measurements on Teletherapy Units |
Section R12-1-735. Full Calibration Measurements on Remote After- loader Units |
Section R12-1-737. Periodic Spot-checks for Teletherapy Units |
Section R12-1-738. Periodic Spot-checks for Remote Afterloader Units |
Section R12-1-739. Periodic Spot-checks for Gamma Stereotactic Radiosurgery Units |
Section R12-1-740. Additional Requirements for Mobile Remote Afterloader Units |
Section R12-1-741. Additional Radiation Surveys of Sealed Sources used in Radiation Therapy |
Section R12-1-742. Five-year Inspection for Teletherapy and Gamma Stereotactic Radiosurgery Units |
Section R12-1-743. Therapy-related Computer Systems |
Section R12-1-744. Training for Use of Remote Afterloader Units, Teletherapy Units, and Gamma Stereotactic Radiosurgery Units |
Section R12-1-745. Report and Notification of a Medical Event |
Section R12-1-746. Report and Notification of a Dose to an Embryo, Fetus, or Nursing Child |
Exhibit A. Medical Use Groups Group 100 |